Kidney Week

Translational Session

Treatment Development in IgA Nephropathy

November 04, 2023 | 04:30 PM - 06:00 PM

Location: Room 201, Pennsylvania Convention Center

Session Description

IgA nephropathy is a rare kidney disease that, until recently, had no treatment options. Over the last decade, a robust pipeline of treatment options for IgA nephropathy are in clinical trials. This session highlights patient perspective, trial design, emerging therapies, and the collaboration between the US Food and Drug Administration (FDA), investigators, and industry required to make new therapies possible.

ASN thanks the Kidney Health Initiative for assistance with this session.
Session support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

• Examine the trial design and endpoints in IgA nephropathy
• Discuss the perspective of a parent whose child was diagnosed with IgA nephropathy
• Explain how collaborations among researchers, industry, and the FDA opened opportunities for new translational science
• Summarize emerging therapies in IgA nephropathy

Learning Pathway(s)

• Glomerular Diseases
• CKD Non-Dialysis

Moderators

• Mark D. Lim, PhD
• Patrick H. Nachman, MD, FASN

Presentations

• Perspective and Journey of a Parent Diagnosed with IgA Nephropathy
  04:30 PM - 04:50 PM
  
  • Judy Akin
  Judy Akin

Perspective and Journey of a Parent Diagnosed with IgA Nephropathy

November 04, 2023 | 04:30 PM - 04:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Trial Design and Endpoints in IgA Nephropathy
  04:50 PM - 05:10 PM
  
  • Heather N. Reich, MD, PhD
  Heather N. Reich, MD, PhD

Trial Design and Endpoints in IgA Nephropathy

November 04, 2023 | 04:50 PM - 05:10 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Regulatory Pathways for Drug Development, Including the Accelerated Approval Pathway
  05:10 PM - 05:30 PM
  
  • Aliza M. Thompson, MD, MS
  Aliza M. Thompson, MD, MS

Regulatory Pathways for Drug Development, Including the Accelerated Approval Pathway

November 04, 2023 | 05:10 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Emerging Therapies in IgA Nephropathy
  05:30 PM - 05:50 PM
  
  • Dana V. Rizk, MD
  Dana V. Rizk, MD

Emerging Therapies in IgA Nephropathy

November 04, 2023 | 05:30 PM - 05:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Q&A
  05:50 PM - 06:00 PM
  

Q&A

November 04, 2023 | 05:50 PM - 06:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.